Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
NCT02527265
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL:
Afrezza
Sponsor
Mannkind Corporation